Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...51525354555657585960...
CompanyDrug NameStatusIndication Group
Amgen Aranesp Approved in USABlood & blood forming organs
Amgen Aranesp in Phase IIICardiovascular system
MGI PHARMA Aquavan Submitted for approval in USANervous system
OSI Aptosyn and Taxotere discontinuedAntineoplastic & immunomodulating agents
Paladin Labs Aptosin in Phase IIIAntineoplastic & immunomodulating agents
Boehringer Ingelheim Aptivus Approved in EU and USAAnti-infectives for systemic use
Wyeth Aprela in Phase IIIGenito urinary system & sex hormones
Sanofi-aventis Approvel Approved in USAGenito urinary system & sex hormones
Nastech apomorphine intranasal accomplished Phase IIGenito urinary system & sex hormones
Bertek Pharmaceutical Apokyn Approved in USANervous system
PharmaMar Aplidin accomplished Phase IIAntineoplastic & immunomodulating agents
PharmaMar Aplidin in Phase IIAntineoplastic & immunomodulating agents
GlaxoSmithKline Aplaviroc discontinuedAnti-infectives for systemic use
Sanofi-aventis Apidra Approved in USA and EUAlimentary tract & metabolism
GlaxoSmithKline Apan in Phase IINervous system
Active Biotech Anyara and Taxotere in Phase IAntineoplastic & immunomodulating agents
Active Biotech Anyara accomplished Phase IIAntineoplastic & immunomodulating agents
Active Biotech Anyara accomplished Phase IIAntineoplastic & immunomodulating agents
Pharmacyclics Antrin accomplished Phase ICardiovascular system
Roche Antevas Submitted for approval in JapanCardiovascular system
...51525354555657585960...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.